{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:19:06Z","timestamp":1761718746681,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R43AI098330\u201001"],"award-info":[{"award-number":["1R43AI098330\u201001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1RC1AI078519","HHSN272201700008C"],"award-info":[{"award-number":["1RC1AI078519","HHSN272201700008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejpb.2018.12.011","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:06:52Z","timestamp":1545422812000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bioanalytical method development and validation for determination of fibroblast growth factor peptide and its application to pharmacokinetic studies"],"prefix":"10.1016","volume":"135","author":[{"given":"Ing-orn","family":"Prasanchaimontri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardik","family":"Chandasana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-2805","authenticated-orcid":false,"given":"Steven","family":"Swarts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Okuneiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2018.12.011_b0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2307\/3579856","article-title":"In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H Mice","volume":"150","author":"Okunieff","year":"1998","journal-title":"Radiat. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2009.11.026","article-title":"Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation","volume":"77","author":"Zhang","year":"2010","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijrobp.2011.02.004","article-title":"Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation","volume":"81","author":"Zhang","year":"2011","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"key":"10.1016\/j.ejpb.2018.12.011_b0020","series-title":"Oxygen Transport to Tissue XXXIV","first-page":"155","article-title":"Fibroblast growth factor-peptide promotes bone marrow recovery after irradiation","author":"Ma","year":"2013"},{"issue":"6","key":"10.1016\/j.ejpb.2018.12.011_b0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/HP.0000000000000095","article-title":"A basic fibroblast growth factor analog for protection and mitigation against acute radiation syndromes","volume":"106","author":"Casey-Sawicki","year":"2014","journal-title":"Health Phy."},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijrobp.2008.09.009","article-title":"Timing of lethality from gastrointestinal syndrome in mice revisited","volume":"73","author":"Rotolo","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejpb.2018.12.011_b0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpba.2013.05.013","article-title":"Determination of an unstable pentapeptide, monocyte locomotion inhibitory factor, in dog blood by LC\u2013MS\/MS: application to a pharmacokinetic study","volume":"83","author":"Jiang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"20","key":"10.1016\/j.ejpb.2018.12.011_b0040","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1021\/ac402420v","article-title":"Fully validated LC-MS\/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum","volume":"85","author":"Jiang","year":"2013","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2018.12.011_b0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpba.2005.01.024","article-title":"Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC\u2013MS\/MS","volume":"38","author":"Chang","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2018.12.011_b0050","article-title":"Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC\u2013MS\/MS","author":"Gudlawar","year":"2013","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpha.2012.10.006","article-title":"Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC\u2013MS\/MS: method development, validation and application to pharmacokinetics","volume":"3","author":"Li","year":"2013","journal-title":"J. Pharm. Anal."},{"issue":"24","key":"10.1016\/j.ejpb.2018.12.011_b0060","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1002\/rcm.3319","article-title":"Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography\/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up","volume":"21","author":"Murao","year":"2007","journal-title":"Rap. Commun. Mass Spectrom."},{"key":"10.1016\/j.ejpb.2018.12.011_b0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jchromb.2013.12.023","article-title":"Determination of BmKCT-13, a chlorotoxin-like peptide, in rat plasma by LC\u2013MS\/MS: application to a preclinical pharmacokinetic study","volume":"947\u2013948","author":"Zang","year":"2014","journal-title":"J. Chromatogr. B"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2018.12.011_b0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jchromb.2006.12.053","article-title":"Quantitative analysis of tenecteplase in rat plasma samples using LC\u2013MS\/MS as an alternative for ELISA","volume":"852","author":"Buscher","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"7","key":"10.1016\/j.ejpb.2018.12.011_b0075","doi-asserted-by":"crossref","first-page":"e0134427","DOI":"10.1371\/journal.pone.0134427","article-title":"Degradation and stabilization of peptide hormones in human blood specimens","volume":"10","author":"Yi","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C3AY41305E","article-title":"Estimation of angiotensin peptides in biological samples by LC\/MS method","volume":"6","author":"Ali","year":"2014","journal-title":"Anal. Meth.: Adv. Meth. Appl."},{"issue":"11\u201312","key":"10.1016\/j.ejpb.2018.12.011_b0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/prca.201300034","article-title":"Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS\/MS","volume":"7","author":"Ceglarek","year":"2013","journal-title":"Proteomics \u2013 Clin. Appl."},{"issue":"20","key":"10.1016\/j.ejpb.2018.12.011_b0090","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1021\/ac4015116","article-title":"High-sensitivity LC-MS\/MS quantification of peptides and proteins in complex biological samples: the impact of enzymatic digestion and internal standard selection on method performance","volume":"85","author":"Bronsema","year":"2013","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.ejpb.2018.12.011_b0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bp970057y","article-title":"Peptide stability in solids and solutions","volume":"13","author":"Bell","year":"1997","journal-title":"Biotechnol. Progress"},{"issue":"1448","key":"10.1016\/j.ejpb.2018.12.011_b0100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1098\/rstb.2004.1500","article-title":"Protein structure, stability and solubility in water and other solvents","volume":"359","author":"Pace","year":"2004","journal-title":"Philos. Trans. Royal Soc. B: Biol. Sci."},{"key":"10.1016\/j.ejpb.2018.12.011_b0105","series-title":"Formulation, Characterization, and Stability of Protein Drugs: Case Histories","first-page":"141","article-title":"Characterization, stability, and formulations of basic fibroblast growth factor","author":"Wang","year":"2002"},{"issue":"5","key":"10.1016\/j.ejpb.2018.12.011_b0110","doi-asserted-by":"crossref","first-page":"e0122419","DOI":"10.1371\/journal.pone.0122419","article-title":"Adsorption of cationic peptides to solid surfaces of glass and plastic","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2018.12.011_b0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejps.2003.10.008","article-title":"Adsorption of the decapeptide cetrorelix depends both on the composition of dissolution medium and the type of solid surface","volume":"21","author":"Grohganz","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2011.02.009","article-title":"The importance of using the optimal plasticware and glassware in studies involving peptides","volume":"414","author":"Goebel-Stengel","year":"2011","journal-title":"Anal. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2018.12.011_b0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cccn.2003.10.026","article-title":"The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma","volume":"340","author":"Belenky","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/CP:1:1:017","article-title":"An investigation of plasma collection, stabilization, and storage procedures for proteomic analysis of clinical samples","volume":"1","author":"Hulmes","year":"2004","journal-title":"Clin. Proteomics"},{"issue":"1","key":"10.1016\/j.ejpb.2018.12.011_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1530\/EC-14-0126","article-title":"Stability of glucagon-like peptide 1 and glucagon in human plasma","volume":"4","author":"Wewer Albrechtsen","year":"2015","journal-title":"Endocrine Connections"},{"key":"10.1016\/j.ejpb.2018.12.011_b0140","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gks400","article-title":"ExPASy: SIB bioinformatics resource portal","volume":"40(Web Server issue)","author":"Artimo","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ejpb.2018.12.011_b0145","first-page":"145","article-title":"Protease inhibition in theory and practice","volume":"3","author":"Garcia-Carreno","year":"1992","journal-title":"Biotechnol. Educ."},{"issue":"4","key":"10.1016\/j.ejpb.2018.12.011_b0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7171\/jbt.13-2404-005","article-title":"The use of ammonium formate as a mobile-phase modifier for LC-MS\/MS analysis of tryptic digests","volume":"24","author":"Johnson","year":"2013","journal-title":"J. Biomol. Techniq.: JBT"},{"issue":"2","key":"10.1016\/j.ejpb.2018.12.011_b0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography\u2013tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejpb.2018.12.011_b0160","article-title":"Approaches to analyzing therapeutic peptides and proteins by LC-MS\/MS","author":"Ewles","year":"2010","journal-title":"White Paper"},{"issue":"16","key":"10.1016\/j.ejpb.2018.12.011_b0165","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1021\/ac501837t","article-title":"A Novel and cost effective method of removing excess albumin from plasma\/serum samples and its impacts on LC-MS\/MS bioanalysis of therapeutic proteins","volume":"86","author":"Liu","year":"2014","journal-title":"Anal. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118309330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118309330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:45:31Z","timestamp":1565232331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118309330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":33,"alternative-id":["S0939641118309330"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.12.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioanalytical method development and validation for determination of fibroblast growth factor peptide and its application to pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}